Moon C, Belabed M, Park M, Mattiuz R, Puleston D, Merad M
Nat Rev Cancer. 2025; .
PMID: 39920276
DOI: 10.1038/s41568-024-00787-3.
Hussain Z, Zhang Y, Qiu L, Gou S, Liu K
NPJ Vaccines. 2025; 10(1):27.
PMID: 39920156
PMC: 11806010.
DOI: 10.1038/s41541-025-01084-2.
Jo S, Ohara R, Theisen D, Kim S, Liu T, Bullock C
J Exp Med. 2025; 222(4).
PMID: 39918736
PMC: 11804880.
DOI: 10.1084/jem.20240955.
Guo W, Zhang X, Wan L, Wang Z, Han M, Yan Z
J Pharm Anal. 2025; 14(12):100953.
PMID: 39845709
PMC: 11751524.
DOI: 10.1016/j.jpha.2024.02.007.
Ouyang C, Huang J, Huang G, Wang Y
Int J Med Sci. 2025; 22(2):417-431.
PMID: 39781535
PMC: 11704690.
DOI: 10.7150/ijms.105532.
Leukocyte-lymphatic intersections during cardiac inflammation.
Glinton K, Thakkar A, Jones R, Inui H, Ge Z, Thorp E
J Mol Cell Cardiol. 2024; 198():13-20.
PMID: 39592090
PMC: 11717605.
DOI: 10.1016/j.yjmcc.2024.11.006.
The IL-1β inhibitor canakinumab in previously treated lower-risk myelodysplastic syndromes: a phase 2 clinical trial.
Rodriguez-Sevilla J, Adema V, Chien K, Loghavi S, Ma F, Yang H
Nat Commun. 2024; 15(1):9840.
PMID: 39537648
PMC: 11561093.
DOI: 10.1038/s41467-024-54290-2.
An IL-2 mutein increases regulatory T cell suppression of dendritic cells via IL-10 and CTLA-4 to promote T cell anergy.
Jamison B, Lawrance M, Wang C, DeBerg H, Ziegler L, Sansom D
Cell Rep. 2024; 43(11):114938.
PMID: 39488830
PMC: 11602548.
DOI: 10.1016/j.celrep.2024.114938.
Inhaled GM-CSF administered during ongoing pneumovirus infection alters myeloid and CD8 T cell immunity without affecting disease outcome.
Debeuf N, Deckers J, Lameire S, Bosteels C, Hammad H, Lambrecht B
Front Immunol. 2024; 15:1439789.
PMID: 39439800
PMC: 11493702.
DOI: 10.3389/fimmu.2024.1439789.
Striking a balance: new perspectives on homeostatic dendritic cell maturation.
Bosteels V, Janssens S
Nat Rev Immunol. 2024; 25(2):125-140.
PMID: 39289483
DOI: 10.1038/s41577-024-01079-5.
CD91 and Its Ligand gp96 Confer Cross-Priming Capabilities to Multiple APCs during Immune Responses to Nascent, Emerging Tumors.
Nayak D, Sedlacek A, Cillo A, Watkins S, Binder R
Cancer Immunol Res. 2024; 12(12):1663-1676.
PMID: 39269437
PMC: 11614702.
DOI: 10.1158/2326-6066.CIR-24-0326.
Enhancing radiotherapy response via intratumoral injection of a TLR9 agonist in autochthonous murine sarcomas.
Su C, Kent C, Pierpoint M, Floyd W, Luo L, Williams N
JCI Insight. 2024; 9(14).
PMID: 39133651
PMC: 11383182.
DOI: 10.1172/jci.insight.178767.
STING agonist-conjugated metal-organic framework induces artificial leukocytoid structures and immune hotspots for systemic antitumor responses.
Luo T, Jiang X, Fan Y, Yuan E, Li J, Tillman L
Natl Sci Rev. 2024; 11(7):nwae167.
PMID: 38887543
PMC: 11182667.
DOI: 10.1093/nsr/nwae167.
Meteorin-like protein/METRNL/Interleukin-41 ameliorates atopic dermatitis-like inflammation.
Huang D, Liu X, Gao X, Choi C, Giglio G, Farah L
Allergy. 2024; 80(2):474-488.
PMID: 38727640
PMC: 11804313.
DOI: 10.1111/all.16150.
CCR5 promotes the migration of pathological CD8+ T cells to the leishmanial lesions.
Amorim Sacramento L, Farias Amorim C, G Lombana C, Beiting D, Novais F, Carvalho L
PLoS Pathog. 2024; 20(5):e1012211.
PMID: 38709823
PMC: 11098486.
DOI: 10.1371/journal.ppat.1012211.
Coordinated chemokine expression defines macrophage subsets across tissues.
Li X, Mara A, Musial S, Kolling F, Gibbings S, Gerebtsov N
Nat Immunol. 2024; 25(6):1110-1122.
PMID: 38698086
PMC: 11565582.
DOI: 10.1038/s41590-024-01826-9.
Dendritic Cell-Based Immunotherapy: The Importance of Dendritic Cell Migration.
Song M, Nam J, Noh K, Lim D
J Immunol Res. 2024; 2024:7827246.
PMID: 38628676
PMC: 11019573.
DOI: 10.1155/2024/7827246.
Tissue-Resident Alveolar Macrophages Reduce Ozone-induced Inflammation via MerTK-mediated Efferocytosis.
Guttenberg M, Vose A, Birukova A, Lewars K, Cumming R, Albright M
Am J Respir Cell Mol Biol. 2024; 70(6):493-506.
PMID: 38386777
PMC: 11160417.
DOI: 10.1165/rcmb.2023-0390OC.
Enhancing radiotherapy response via intratumoral injection of the TLR9 agonist CpG to stimulate CD8 T cells in an autochthonous mouse model of sarcoma.
Su C, Kent C, Pierpoint M, Floyd W, Luo L, Wiliams N
bioRxiv. 2024; .
PMID: 38260522
PMC: 10802286.
DOI: 10.1101/2024.01.03.573968.
CCL5 promotes the proliferation and metastasis of bladder cancer via the JAK2/STAT3 signaling pathway.
Shen J, Chen C, Chen Z, Gong P, Lee L, Schmeusser B
Transl Androl Urol. 2024; 12(12):1845-1858.
PMID: 38196701
PMC: 10772649.
DOI: 10.21037/tau-23-540.